Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493).
about
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493).
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Phase 2 trial of infusional cy ...... Oncology Group trial (E3493).
@ast
Phase 2 trial of infusional cy ...... Oncology Group trial (E3493).
@en
type
label
Phase 2 trial of infusional cy ...... Oncology Group trial (E3493).
@ast
Phase 2 trial of infusional cy ...... Oncology Group trial (E3493).
@en
prefLabel
Phase 2 trial of infusional cy ...... Oncology Group trial (E3493).
@ast
Phase 2 trial of infusional cy ...... Oncology Group trial (E3493).
@en
P2093
P1433
P1476
Phase 2 trial of infusional cy ...... e Oncology Group trial (E3493)
@en
P2093
Ann E Traynor
Edie Weller
Jane Manalo
Joseph A Sparano
Peter Cassileth
Thomas Habermann
Tipu Nazeer
P304
P407
P577
2002-09-01T00:00:00Z